Connect to other sites within the UBM Medica Network
Preventive options are scarce. What about cognitive behavioral therapy?
Statins Plus Exercise: New Study Questions the Combination
Simvastatin 40 mg once daily can attenuate increases in cardiorespiratory fitness in response to exercise training.
Women and Heart Disease: Incidence, Prevalence, Progress, and the Future
Female CV mortality lags behind male mortality; lifetime risk assessment, not 10-year risk, is a better estimation tool for women
The Mediterranean Diet in Primary Cardiovascular Prevention
Patients who consumed a Mediterranean-style diet had a 30% reduction in major cardiovascular events compared with patients who ate a diet low in saturated fat.
DPP-4 Antagonists: Benefits, Risks, and the Future
Dipeptidyl peptidase-4 inhibitors, of the incretin class of antidiabetes drugs, are weight neutral, avoid hypoglycemia, and result in an average reduction in HbA1c of 0.5% to 1.0%
Lipid-lowering Injectable Antibodies: The Next Big Thing?
PCSK-9 inhibition in patients with recalcitrant hypercholesterolemia has reaped reductions in LDL-C of up to 85% after the first week of therapy.
AHA 2012 Highlights: Multivitamins, Omega-3s, the Polypill, and More
Platelet function monitoring and adjustment of treatment based on results after coronary stenting does not improve clinical outcomes . . . and other findings from the AHA Scientific Sessions.
Who Needs Beta-Blockers? Analysis Raises Questions
A new analysis of data from a large international registry finds that use of beta-blockers in patients with and without a history of coronary artery disease does not reduce cardiovascular events.
By clicking Accept, you agree to become a member of the UBM Medica Community.